NASDAQ:ACRX
AcelRx Pharmaceuticals, Inc.
- Stock
Last Close
0.80
09/01 21:00
Market Cap
14.58M
Beta: 0.24
Volume Today
241.00K
Avg: 223.92K
PE Ratio
−1.83
PFCF: −0.68
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -23.43M - | -33.35M 42.38% | -24.40M 26.85% | -43.16M 76.88% | -51.51M 19.35% | -47.15M 8.46% | -53.24M 12.92% | -40.38M 24.16% | -35.10M 13.08% | 47.76M 236.06% | -18.40M 138.52% | |
depreciation and amortization | 593K - | 866K 46.04% | 1.98M 129.10% | 2.05M 3.43% | 1.74M 15.01% | 575K 67.03% | 1.67M 190.09% | 1.85M 11.09% | 1.97M 6.48% | 1.65M 16.52% | 311K 81.12% | |
deferred income tax | 15.47M - | -6.82M 144.10% | -1.45M 78.77% | -750K 48.24% | 176K 123.47% | -86K 148.86% | 951K 1,205.81% | 810K - | 703K - | |||
stock based compensation | 3.48M - | 4.44M 27.62% | 5.01M 12.84% | 4.48M 10.60% | 4.29M 4.13% | 5.17M 20.35% | 5.06M 2.15% | 4.42M 12.52% | 4.61M 4.18% | 2.89M 37.32% | 1.73M 40.15% | |
change in working capital | 2.95M - | -138K 104.68% | -4.42M 3,105.80% | -2.27M 48.67% | 3.70M 262.88% | 1.87M 49.53% | -3.91M 309.21% | -2.29M 41.42% | 203K 108.87% | -1.39M 784.73% | -703K 49.42% | |
accounts receivables | 106K - | 90K 15.09% | -3.29M 3,751.11% | -2.55M 22.49% | 4.30M 268.83% | 1.48M 65.49% | -383K 125.81% | -203K 47.00% | 475K 333.99% | -149K 131.37% | -189K 26.85% | |
inventory | 266K - | -79K 129.70% | -466K 489.87% | -1.69M 262.23% | 920K 154.50% | 102K 88.91% | -3.39M 3,425.49% | 957K 128.21% | -295K 130.83% | -107K 63.73% | 61K 157.01% | |
accounts payables | 106K - | 90K 15.09% | -786K 973.33% | -437K 44.40% | 309K 170.71% | 458K 48.22% | -19K 104.15% | 1.02M 5,447.37% | 111K 89.07% | 551K 396.40% | -575K 204.36% | |
other working capital | 2.47M - | -239K 109.67% | 114K 147.70% | 2.40M 2,006.14% | -1.83M 176.22% | -177K 90.33% | -112K 36.72% | -4.06M 3,523.21% | -88K 97.83% | -1.69M 1,814.77% | 703K 141.72% | |
other non cash items | 442K - | 553K 25.11% | 3.33M 501.27% | 10.25M 208.33% | 11.83M 15.39% | 10.55M 10.82% | -1.71M 116.21% | -2.12M 23.68% | -2.50M 18.11% | -79.23M 3,071.82% | -1.14M 98.57% | |
net cash provided by operating activities | -487K - | -34.46M 6,975.15% | -19.95M 42.09% | -29.39M 47.32% | -29.77M 1.26% | -29.07M 2.32% | -51.18M 76.03% | -38.51M 24.77% | -30.00M 22.08% | -28.33M 5.57% | -17.49M 38.26% | |
investments in property plant and equipment | -3.29M - | -5.50M 67.48% | -1.46M 73.55% | -3.72M 155.49% | -2.40M 35.35% | -819K 65.95% | -3.47M 323.69% | -1.85M 46.54% | -1.83M 1.51% | -364K 80.08% | -100K 72.53% | |
acquisitions net | 33.09M - | -35.99M 208.77% | -1.69M - | |||||||||
purchases of investments | -28.01M - | -17.43M 37.77% | -7.27M 58.31% | -996K 86.29% | -7.57M 659.54% | -30.56M 303.94% | -100.07M 227.47% | -44.61M 55.42% | -70.46M 57.94% | -7.86M 88.84% | -3.65M 53.56% | |
sales maturities of investments | 24.38M - | 17.16M 29.61% | 16.93M 1.36% | 6.53M 61.45% | 20.50M - | 66.97M 226.71% | 80.61M 20.35% | 46.98M 41.71% | 46.36M 1.32% | 500K 98.92% | ||
other investing activites | -33.09M - | 35.99M 208.77% | -821K 102.28% | 2.72M - | ||||||||
net cash used for investing activites | -6.92M - | -5.78M 16.53% | 8.20M 242.02% | 1.81M 77.95% | -9.97M 651.13% | -10.88M 9.10% | -36.56M 236.15% | 34.14M 193.37% | -26.12M 176.52% | 36.45M 239.53% | -528K 101.45% | |
debt repayment | -16.78M - | -4.53M - | -3.51M - | -7.72M 119.64% | -12.33M 59.81% | -4.67M 62.16% | -8.83M 89.27% | -8.43M 4.53% | ||||
common stock issued | 47.94M - | 15.69M - | 81.53M 419.47% | 1.23M 98.49% | 21.34M 1,630.49% | 44.72M 109.57% | 7.99M 82.14% | 8.86M 10.89% | ||||
common stock repurchased | -86K - | -249K 189.53% | -315K 26.51% | |||||||||
dividends paid | -86K - | -249K 189.53% | ||||||||||
other financing activites | 16.71M - | 11.87M 28.99% | 64.17M 440.64% | -26K 100.04% | 147K 665.38% | 1.22M 728.57% | 25.55M 1,997.95% | 458K 98.21% | 6.13M 1,238.21% | 255K 95.84% | -5.39M 2,213.73% | |
net cash used provided by financing activities | 47.88M - | 11.87M 75.21% | 59.63M 402.43% | -26K 100.04% | 12.33M 47,511.54% | 75.03M 508.62% | 14.45M 80.74% | 16.96M 17.33% | 41.51M 144.83% | -507K 101.22% | 3.47M 783.63% | |
effect of forex changes on cash | ||||||||||||
net change in cash | 40.47M - | -28.36M 170.09% | 47.88M 268.83% | -27.61M 157.66% | -27.41M 0.74% | 35.07M 227.97% | -73.29M 308.97% | 12.59M 117.18% | -14.61M 216.05% | 7.61M 152.10% | -14.55M 291.20% | |
cash at beginning of period | 47.93M - | 88.40M 84.43% | 60.04M 32.08% | 107.92M 79.76% | 80.31M 25.59% | 53.08M 33.91% | 87.97M 65.74% | 14.68M 83.31% | 27.27M 85.74% | 12.66M 53.57% | 20.27M 60.11% | |
cash at end of period | 88.40M - | 60.04M 32.08% | 107.92M 79.76% | 80.31M 25.59% | 52.90M 34.13% | 88.15M 66.63% | 14.68M 83.34% | 27.27M 85.74% | 12.66M 53.57% | 20.27M 60.11% | 5.72M 71.78% | |
operating cash flow | -487K - | -34.46M 6,975.15% | -19.95M 42.09% | -29.39M 47.32% | -29.77M 1.26% | -29.07M 2.32% | -51.18M 76.03% | -38.51M 24.77% | -30.00M 22.08% | -28.33M 5.57% | -17.49M 38.26% | |
capital expenditure | -3.29M - | -5.50M 67.48% | -1.46M 73.55% | -3.72M 155.49% | -2.40M 35.35% | -819K 65.95% | -3.47M 323.69% | -1.85M 46.54% | -1.83M 1.51% | -364K 80.08% | -100K 72.53% | |
free cash flow | -3.77M - | -39.96M 958.85% | -21.41M 46.43% | -33.12M 54.68% | -32.17M 2.85% | -29.89M 7.07% | -54.65M 82.81% | -40.36M 26.15% | -31.83M 21.14% | -28.70M 9.85% | -17.59M 38.69% |
All numbers in USD (except ratios and percentages)